8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Mar 18, 2026·SEC
Material company update
Jan 8, 2026·SEC
Sera Prognostics, Inc.(SERA)Earnings, Financials & Key Ratios
SERA•NASDAQ
Price updated Jun 19, 2026
AboutSera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.Show more
- Revenue$81K+5.2%
- EBITDA-$36M+0.7%
- Net Income-$32M+2.9%
- EPS (Diluted)-0.67+32.3%
- Gross Margin-102.47%-1478.0%
- EBITDA Margin-43906.17%+5.6%
- Operating Margin-45066.67%+5.3%
- Net Margin-39417.28%+7.7%
- ROE-51.83%+7.1%
SERA Key Insights
Sera Prognostics, Inc. (SERA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y sales CAGR of 26.5%
- ✓Trading at only 1.1x book value
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 12 (bottom 12%)
- ✗Shares diluted 43.7% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when SERA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
SERA Price & Volume
Sera Prognostics, Inc. (SERA) stock price & volume — 10-year historical chart
Loading chart...
SERA Growth Metrics
Sera Prognostics, Inc. (SERA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years26.51%
3 Years-32.89%
TTM-50.43%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM2.57%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM30.85%
Return on Capital
10 Years-74.5%
5 Years-50.82%
3 Years-55.39%
Last Year-58.15%
SERA Recent Earnings
Sera Prognostics, Inc. (SERA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 2/12 qtrs (17%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$0.17-6.3%
$0.16
Rev
$14,000-79.0%
$66,667
Q2 2026
Mar 18, 2026Metric
Actual
Est
EPS
$0.16+5.9%
$0.17
Rev
$10,000-68.5%
$31,767
Q4 2025
Nov 13, 2025Metric
Actual
Est
EPS
$0.16+15.8%
$0.19
Rev
$16,000-68.2%
$50,350
Q3 2025
Aug 6, 2025Metric
Actual
Est
EPS
$0.16+23.8%
$0.21
Rev
$17,000-88.7%
$150,000
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.17vs $0.16-6.3% | $14,000vs $66,667-79.0% |
| Q2 2026 | Mar 18, 2026 | $0.16vs $0.17+5.9% | $10,000vs $31,767-68.5% |
| Q4 2025 | Nov 13, 2025 | $0.16vs $0.19+15.8% | $16,000vs $50,350-68.2% |
| Q3 2025 | Aug 6, 2025 | $0.16vs $0.21+23.8% | $17,000vs $150,000-88.7% |
Based on last 12 quarters of dataView full earnings history →
SERA Peer Comparison
Sera Prognostics, Inc. (SERA) competitors in Molecular and Genetic Diagnostics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 NTRA | 33.14B | 231.41 | -152.24 | 35.9% | -9.05% | -15.13% | 0.13 | |
 PGNY | 2.04B | 26.08 | 40.12 | 10.4% | 5.23% | 13.34% | 0.05 | |
 OVID | 299.38M | 2.27 | -9.46 | 11.81% | -339.33% | -22.51% | 0.10 | |
 INVA | 1.66B | 22.49 | 6.82 | 18.52% | 118.91% | 47.59% | 0.23 | |
 ILMN | 24.6B | 161.93 | 29.71 | -0.78% | 19.43% | 32.84% | 0.94 | |
 EXAS | 20.02B | 104.91 | -95.37 | 17.69% | -6.4% | -8.66% | 1.05 | |
 CSTL | 640.57M | 21.12 | -25.45 | 3.66% | -3.77% | -2.77% | 0.08 | |
 LH | 21.05B | 255.82 | 24.46 | 7.25% | 6.66% | 10.89% | 0.83 |
Compare SERA vs Peers
Sera Prognostics, Inc. (SERA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SERA Income Statement
Sera Prognostics, Inc. (SERA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 36K | 25K | 82K | 268K | 306K | 77K | 81K | 57K |
Revenue Growth % | - | -30.56% | 228% | 226.83% | 14.18% | -74.84% | 5.19% | -50.43% |
Cost of Goods Sold | 18K | 11K | 37K | 193K | 210K | 82K | 164K | 166K |
COGS % of Revenue | 50% | 44% | 45.12% | 72.01% | 68.63% | 106.49% | 202.47% | - |
Gross Profit | 18K▲ 0% | 14K▼ 22.2% | 45K▲ 221.4% | 75K▲ 66.7% | 96K▲ 28.0% | -5K▼ 105.2% | -83K▼ 1560.0% | -109K▲ 0% |
Gross Margin % | 50% | 56% | 54.88% | 27.99% | 31.37% | -6.49% | -102.47% | -191.23% |
Gross Profit Growth % | - | -22.22% | 221.43% | 66.67% | 28% | -105.21% | -1560% | - |
Operating Expenses | 16.59M | 17.98M | 35.44M | 45.73M | 39.92M | 36.63M | 36.42M | 36.51M |
OpEx % of Revenue | 46094.44% | 71940% | 43219.51% | 17062.31% | 13044.77% | 47571.43% | 44964.2% | - |
Selling, General & Admin | 7.24M | 10.2M | 24.42M | 31.48M | 24.69M | 21.9M | 23.25M | 23.64M |
SG&A % of Revenue | 20113.89% | 40812% | 29781.71% | 11747.39% | 8069.28% | 28441.56% | 28703.7% | - |
Research & Development | 9.35M | 7.78M | 11.02M | 14.24M | 15.22M | 14.73M | 13.17M | 12.87M |
R&D % of Revenue | 25980.56% | 31128% | 13437.8% | 5314.93% | 4975.49% | 19129.87% | 16260.49% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -16.58M▲ 0% | -17.97M▼ 8.4% | -35.4M▼ 97.0% | -45.65M▼ 29.0% | -39.82M▲ 12.8% | -36.63M▲ 8.0% | -36.5M▲ 0.4% | -36.61M▲ 0% |
Operating Margin % | -46044.44% | -71884% | -43164.63% | -17034.33% | -13013.4% | -47577.92% | -45066.67% | -64235.09% |
Operating Income Growth % | - | -8.42% | -96.96% | -28.98% | 12.77% | 8% | 0.36% | - |
EBITDA | -15.63M | -17.08M | -34.74M | -44.9M | -38.92M | -35.8M | -35.56M | -35.89M |
EBITDA Margin % | -43416.67% | -68304% | -42360.98% | -16752.24% | -12719.28% | -46496.1% | -43906.17% | -62964.91% |
EBITDA Growth % | - | -9.25% | -103.42% | -29.25% | 13.31% | 8.01% | 0.66% | 0.17% |
D&A (Non-Cash Add-back) | 946K | 895K | 659K | 756K | 900K | 833K | 940K | 724K |
EBIT | -14.55M | -18.01M | -34.26M | -44.13M | -36.19M | -32.87M | -36.5M | -33.1M |
Net Interest Income | -1.91M | -1.8M | -601K | 395K | 1.58M | 2.72M | 4.58M | 2.31M |
Interest Income | 64K | 42K | 145K | 456K | 1.64M | 2.75M | 4.58M | 2.31M |
Interest Expense | 1.97M | 1.84M | 746K | 61K | 55K | 28K | 9K | 3K |
Other Income/Expense | 55K | -1.88M | 386K | 1.47M | 3.58M | 3.74M | 4.58M | 4.47M |
Pretax Income | -16.52M▲ 0% | -19.85M▼ 20.1% | -35.01M▼ 76.4% | -44.19M▼ 26.2% | -36.24M▲ 18.0% | -32.9M▲ 9.2% | -31.93M▲ 2.9% | -32.14M▲ 0% |
Pretax Margin % | -45891.67% | -79392% | -42693.9% | -16487.31% | -11843.79% | -42724.68% | -39417.28% | -56385.96% |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Net Income | -16.52M▲ 0% | -19.85M▼ 20.1% | -35.01M▼ 76.4% | -44.19M▼ 26.2% | -36.24M▲ 18.0% | -32.9M▲ 9.2% | -31.93M▲ 2.9% | -32.14M▲ 0% |
Net Margin % | -45891.67% | -79392% | -42693.9% | -16487.31% | -11843.79% | -42724.68% | -39417.28% | -56385.96% |
Net Income Growth % | - | -20.14% | -76.39% | -26.21% | 17.98% | 9.23% | 2.95% | 2.57% |
Net Income (Continuing) | -16.52M | -19.85M | -35.01M | -44.19M | -36.24M | -32.9M | -31.93M | -32.14M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -1.13▲ 0% | -1.19▼ 5.3% | -1.18▲ 0.8% | -1.43▼ 21.2% | -1.16▲ 18.9% | -0.99▲ 14.7% | -0.67▲ 32.3% | -0.64▲ 0% |
EPS Growth % | - | -5.31% | 0.84% | -21.19% | 18.88% | 14.66% | 32.32% | 30.85% |
EPS (Basic) | -1.13 | -1.19 | -1.18 | -1.43 | -1.16 | -0.99 | -0.67 | - |
Diluted Shares Outstanding | 18.11M | 18.11M | 30.77M | 30.94M | 31.2M | 33.16M | 47.66M | 50.26M |
Basic Shares Outstanding | 18.11M | 18.11M | 30.77M | 30.94M | 31.2M | 33.16M | 47.66M | 50.26M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - |
SERA Balance Sheet
Sera Prognostics, Inc. (SERA) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 21.55M | 13.73M | 110.25M | 90.13M | 61.34M | 47.6M | 40.77M | 49.73M |
Cash & Short-Term Investments | 21.39M | 13.53M | 105.11M | 82.7M | 49.08M | 46.24M | 39.2M | 47.4M |
Cash Only | 21.39M | 13.53M | 58.93M | 29.88M | 3.88M | 4.04M | 3.94M | 4.17M |
Short-Term Investments | 0 | 0 | 46.18M | 52.83M | 45.2M | 42.19M | 35.26M | 43.23M |
Accounts Receivable | 1K | 2K | 3.14M | 6.11M | 11.47M | 34K | 12K | 11K |
Days Sales Outstanding | 10.14 | 29.2 | 13.99K | 8.33K | 13.68K | 161.17 | 54.07 | 86.45 |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - |
Other Current Assets | 0 | 0 | 0 | 1.31M | 795K | 19K | 1.56M | 2.31M |
Total Non-Current Assets | 1.71M | 1.06M | 36.78M | 26.2M | 34.1M | 24.98M | 61.16M | 43.82M |
Property, Plant & Equipment | 1.64M | 965K | 1.77M | 3.06M | 3.18M | 1.85M | 1.15M | 1.1M |
Fixed Asset Turnover | 0.02x | 0.03x | 0.05x | 0.09x | 0.10x | 0.04x | 0.07x | 0.05x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 1.03M | 910K | 881K |
Long-Term Investments | 0 | 0 | 34.85M | 21.33M | 30.84M | 21.97M | 0 | 184.01M |
Other Non-Current Assets | 72K | 98K | 157K | 1.82M | 77K | 124K | 59.1M | 41.84M |
Total Assets | 23.26M▲ 0% | 14.8M▼ 36.4% | 147.03M▲ 893.7% | 116.33M▼ 20.9% | 95.44M▼ 18.0% | 72.58M▼ 24.0% | 101.93M▲ 40.5% | 93.54M▲ 0% |
Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
Asset Growth % | - | -36.39% | 893.71% | -20.88% | -17.96% | -23.96% | 40.45% | 88.25% |
Total Current Liabilities | 5.9M | 11.24M | 8.41M | 15.54M | 24.44M | 24.77M | 24.19M | 23.42M |
Accounts Payable | 748K | 441K | 1.2M | 1.55M | 1.05M | 1.97M | 862K | 767K |
Days Payables Outstanding | 15.17K | 14.63K | 11.81K | 2.93K | 1.82K | 8.76K | 1.92K | 2.05K |
Short-Term Debt | 3.67M | 8.03M | 0 | 0 | 0 | 0 | 2K | 0 |
Deferred Revenue (Current) | 0 | 0 | 3.12M | 9.08M | 20.23M | 0 | 20.32M | 60.94M |
Other Current Liabilities | 294K | 321K | 3.56M | 1.07M | 926K | 20.52M | 3.01M | 2.34M |
Current Ratio | 3.65x | 1.22x | 13.11x | 5.80x | 2.51x | 1.92x | 1.69x | 2.12x |
Quick Ratio | 3.65x | 1.22x | 13.11x | 5.80x | 2.51x | 1.92x | 1.69x | 2.12x |
Cash Conversion Cycle | - | - | - | - | - | - | - | -1.96K |
Total Non-Current Liabilities | 6.4M | 614K | 54K | 1.85M | 840K | 2K | 2.34M | 2.5M |
Long-Term Debt | 5.44M | 348K | 0 | 0 | 0 | 0 | 0 | 2.5M |
Capital Lease Obligations | 134K | 127K | 54K | 1.85M | 840K | 2K | 2.34M | 2.44M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 823K | 139K | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 12.3M | 11.86M | 8.46M | 17.39M | 25.28M | 24.77M | 26.52M | 25.92M |
Total Debt | 9.31M | 8.57M | 128K | 2.83M | 1.86M | 840K | 2.34M | 2.5M |
Net Debt | -12.07M | -4.96M | -58.8M | -27.05M | -2.02M | -3.2M | -1.6M | -1.67M |
Debt / Equity | 0.85x | 2.92x | 0.00x | 0.03x | 0.03x | 0.02x | 0.03x | 0.04x |
Debt / EBITDA | - | - | - | - | - | - | - | -0.07x |
Net Debt / EBITDA | - | - | - | - | - | - | - | 0.05x |
Interest Coverage | -7.38x | -9.79x | -45.93x | -723.36x | -657.95x | -1173.93x | -4056.00x | -11032.00x |
Total Equity | 10.96M▲ 0% | 2.94M▼ 73.2% | 138.56M▲ 4613.1% | 98.94M▼ 28.6% | 70.16M▼ 29.1% | 47.8M▼ 31.9% | 75.41M▲ 57.7% | 67.62M▲ 0% |
Equity Growth % | - | -73.17% | 4613.06% | -28.59% | -29.09% | -31.86% | 57.75% | 127.12% |
Book Value per Share | 0.61 | 0.16 | 4.50 | 3.20 | 2.25 | 1.44 | 1.58 | 1.35 |
Total Shareholders' Equity | 10.96M | 2.94M | 138.56M | 98.94M | 70.16M | 47.8M | 75.41M | 67.62M |
Common Stock | 0 | 0 | 3K | 3K | 3K | 3K | 4K | 4K |
Retained Earnings | -111.61M | -131.46M | -166.47M | -210.65M | -246.9M | -279.79M | -311.72M | -320.12M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 0 | -183K | -981K | -15K | 60K | 262K | 16K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SERA Cash Flow Statement
Sera Prognostics, Inc. (SERA) cash flow — operating, investing & free cash flow history
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | -19.32M | -16.87M | -31.64M | -34.61M | -27.19M | -14.19M | -25.62M | -26.84M |
Operating CF Margin % | -53677.78% | -67472% | -38580.49% | -12914.18% | -8884.97% | -18427.27% | -31633.33% | - |
Operating CF Growth % | - | 12.71% | -87.55% | -9.4% | 21.44% | 47.81% | -80.58% | 1.15% |
Net Income | -16.52M | -19.85M | -35.01M | -44.19M | -36.24M | -32.9M | -31.93M | -32.14M |
Depreciation & Amortization | 946K | 895K | 659K | 756K | 900K | 833K | 940K | 917K |
Stock-Based Compensation | 438K | 726K | 3.13M | 5.05M | 5.27M | 7.01M | 5.11M | 3.62M |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | -541K | 1.67M | -372K | 213K | -638K | -412K | 801K | 1.53M |
Working Capital Changes | -3.65M | -311K | -44K | 3.55M | 3.52M | 11.28M | -546K | -772K |
Change in Receivables | 6K | -2K | -3.14M | -2.97M | -5.36M | 11.42M | 22K | 14K |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | -534K | -307K | 603K | 352K | -442K | 455K | -1.01M | -83K |
Cash from Investing | -6K | -149K | -82.56M | 5.55M | 438K | 11.74M | -28.5M | 25.29M |
Capital Expenditures | -109K | -149K | -1.3M | -791K | -128K | -56K | -726K | -731K |
CapEx % of Revenue | 302.78% | 596% | 1590.24% | 295.15% | 41.83% | 72.73% | 896.3% | 1282.46% |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - |
Other Investing | 103K | 0 | 0 | 16K | 311K | -1.04M | 0 | -1 |
Cash from Financing | 33.05M | 9.16M | 159.59M | 5K | 752K | 2.61M | 54.03M | 504K |
Debt Issued (Net) | 2.98M | -1.7M | -7.66M | -303K | -466K | -440K | -194K | -81K |
Equity Issued (Net) | 30.05M | 10.69M | 165.59M | 0 | 0 | 0 | 54.22M | 116K |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 15K | 176K | 1.66M | 308K | 1.22M | 3.05M | 0 | 469K |
Net Change in Cash | 13.72M▲ 0% | -7.86M▼ 157.3% | 45.4M▲ 677.8% | -29.05M▼ 164.0% | -26M▲ 10.5% | 163K▲ 100.6% | -99K▼ 160.7% | -1.05M▲ 0% |
Free Cash Flow | -19.43M▲ 0% | -17.02M▲ 12.4% | -32.94M▼ 93.6% | -35.4M▼ 7.5% | -27.32M▲ 22.8% | -15.29M▲ 44.0% | -26.35M▼ 72.3% | -27.57M▲ 0% |
FCF Margin % | -53980.56% | -68068% | -40170.73% | -13209.33% | -8926.8% | -19857.14% | -32529.63% | -48377.19% |
FCF Growth % | - | 12.43% | -93.57% | -7.47% | 22.84% | 44.03% | -72.33% | -1.65% |
FCF per Share | -1.07 | -0.94 | -1.07 | -1.14 | -0.88 | -0.46 | -0.55 | -0.55 |
FCF Conversion (FCF/Net Income) | 1.17x | 0.85x | 0.90x | 0.78x | 0.75x | 0.43x | 0.80x | 0.86x |
Interest Paid | 463K | 250K | 1.19M | 48K | 55K | 28K | 0 | 3K |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SERA Key Ratios
Sera Prognostics, Inc. (SERA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -285.66% | -49.48% | -37.21% | -42.86% | -55.78% | -51.83% | -41.02% |
Return on Invested Capital (ROIC) | - | -68.29% | -45.15% | -42.66% | -48.74% | -46.25% | -36.15% |
Gross Margin | 56% | 54.88% | 27.99% | 31.37% | -6.49% | -102.47% | -191.23% |
Net Margin | -79392% | -42693.9% | -16487.31% | -11843.79% | -42724.68% | -39417.28% | -56385.96% |
Debt / Equity | 2.92x | 0.00x | 0.03x | 0.03x | 0.02x | 0.03x | 0.04x |
Interest Coverage | -9.79x | -45.93x | -723.36x | -657.95x | -1173.93x | -4056.00x | -11032.00x |
FCF Conversion | 0.85x | 0.90x | 0.78x | 0.75x | 0.43x | 0.80x | 0.86x |
Revenue Growth | -30.56% | 228% | 226.83% | 14.18% | -74.84% | 5.19% | -50.43% |
Related:SERA Dividend History·SERA Revenue History·SERA Price History·SERA P/E History·SERA Financial Ratios·SERA Institutional Holders
SERA SEC Filings & Documents
Sera Prognostics, Inc. (SERA) SEC filings — annual & quarterly reports (10-K, 10-Q)
SERA Frequently Asked Questions
Sera Prognostics, Inc. (SERA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Sera Prognostics, Inc. (SERA) reported $0.1M in revenue for fiscal year 2025. This represents a 58% increase from $0.0M in 2019.
Sera Prognostics, Inc. (SERA) grew revenue by 5.2% over the past year. This is steady growth.
Sera Prognostics, Inc. (SERA) reported a net loss of $32.1M for fiscal year 2025.
Dividend & Returns
Sera Prognostics, Inc. (SERA) has a return on equity (ROE) of -51.8%. Negative ROE indicates the company is unprofitable.
Sera Prognostics, Inc. (SERA) had negative free cash flow of $27.6M in fiscal year 2025, likely due to heavy capital investments.